In a large cohort of IBD patients and controls, it has been demonstrated that 43 bacterial taxa were highly coated with sIgA and, in addition, immuno-therapy changes the microbiota-specific IgA responses with respect to controls [29]. This evidence concerns the gene CD79A and irritable bowel syndrome.